| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4809332 | F | Antiviral activity against Human coronavirus 229E infected in human embryonic lung fibroblast cells assessed as reduction in virus-induced cytopathic effect incubated for 5 days by MTS cell viability assay | Human coronavirus 229E | 25 | ALA4808183 | cell-based format | Scientific Literature | |
| 2. | ALA4809333 | F | Antiviral activity against Human coronavirus 229E infected in human embryonic lung fibroblast cells assessed as reduction in virus-induced cytopathic effect incubated for 5 days by microscopy | Human coronavirus 229E | 25 | ALA4808183 | cell-based format | Scientific Literature | |
| 3. | ALA4809334 | A | Cytotoxicity against mock-infected human embryonic lung fibroblast cells incubated for 5 days by MTS assay | Homo sapiens | 25 | ALA4808183 | cell-based format | Scientific Literature | |
| 4. | ALA4809335 | T | Selectivity index, ratio of CC50 for cytotoxicity against mock-infected human embryonic lung fibroblast cells incubated for 5 days by MTS assay to EC50 for antiviral activity against Human coronavirus 229E infected in human embryonic lung fibroblast cells assessed as reduction in virus-induced cytopathic effect incubated for 5 days by MTS cell viability assay | 22 | ALA4808183 | cell-based format | Scientific Literature | ||
| 5. | ALA4809336 | F | Antiviral activity against SARS-CoV-2 infected in eGFP expressing Vero E6 cells assessed as reduction in virus-induced cytopathic effect cells pretreated for 24 hrs measure after 4 days post infection by MTS cell viability assay | Severe acute respiratory syndrome coronavirus 2 | 2 | ALA4808183 | organism-based format | Scientific Literature | |
| 6. | ALA4809340 | F | Antiviral activity against HIV | Human immunodeficiency virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 7. | ALA4809341 | F | Antiviral activity against Herpes simplex virus | Herpes simplex virus unknown type | 21 | ALA4808183 | assay format | Scientific Literature | |
| 8. | ALA4809342 | F | Antiviral activity against Vaccinia virus | Vaccinia virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 9. | ALA4809343 | F | Antiviral activity against Adenovirus | Human adenovirus 2 | 21 | ALA4808183 | assay format | Scientific Literature | |
| 10. | ALA4809344 | F | Antiviral activity against Vesicular stomatitis virus | Vesicular stomatitis virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 11. | ALA4809345 | F | Antiviral activity against Coxsackie B4 virus | Coxsackievirus B4 | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 12. | ALA4809346 | F | Antiviral activity against Respiratory syncytial virus | Respiratory syncytial virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 13. | ALA4809347 | F | Antiviral activity against Parainfluenza-3 virus | Human respirovirus 3 | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 14. | ALA4809348 | F | Antiviral activity against Reovirus-1 | Reovirus sp. | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 15. | ALA4809349 | F | Antiviral activity against Sindbis virus | Sindbis virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 16. | ALA4809350 | F | Antiviral activity against Punta Toro virus | Punta Toro virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 17. | ALA4809351 | F | Antiviral activity against Yellow fever virus | Yellow fever virus | 21 | ALA4808183 | organism-based format | Scientific Literature | |
| 18. | ALA4809352 | F | Antiviral activity against Influenza virus | Influenza A virus | 21 | ALA4808183 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!